Safety of early antiplatelet administration in patients with acute ischemic stroke treated with alteplase (SEAPT-24)

Alteplase, a tissue-type plasminogen activator, is recommended for ischemic stroke patients presenting within 4.5 h. Due to bleeding risks, current guidelines advise delaying antiplatelet therapy for 24 h after alteplase. However, specific scenarios may require antiplatelet therapy to be given withi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of stroke and cerebrovascular diseases 2022-12, Vol.31 (12), p.106868-106868, Article 106868
Hauptverfasser: Wells, Drew A., Davis, Lyndsey K., Saeed, Omar, Jones, G. Morgan, Elangovan, Cheran, Alexandrov, Andrei V., Krishnaiah, Balaji, March, Katherine L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!